comparemela.com

Latest Breaking News On - Leibniz institute for primate research - Page 5 : comparemela.com

New Omicron subvariant resistant to all antibody therapies: Indian-origin scientist

Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all approved antibody therapies, a new Lancet study led by an Indian-origin researcher has revealed.The researchers found that the Omicron subvariant BQ.1.1 could not .

Germany
New-delhi
Delhi
India
German
Stefan-pohlmann
Markus-hoffmann
Prerna-arora
German-primate-center
Leibniz-institute-for-primate-research
Division-of-molecular-immunology
Lancet-infectious

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

Germany
German
Markus-hoffmann
Prerna-arora
German-primate-center
Leibniz-institute-for-primate-research
Division-of-molecular-immunology
Friedrich-alexander-university-erlangen
Leibniz-institute
Primate-research
Friedrich-alexander-university-erlangen-n
Lancet-infectious-diseases

vimarsana © 2020. All Rights Reserved.